Biotech Values

[ThomasS]

O/T: "But most of the MNTA investors on this board are small timers..." What is your point?
This "small-timer" was also burned: In the Fall of 2008/Spring 2009

1. I failed to buy BAC at $3 when Big-timers knew bankruptcy was imminent.
2. I failed to buy AXP at $10 when Big-timers knew that all Green/Gold/Platinum cards would be shredded.
3. I failed to buy GE at $7 when Big-timers knew they were failing.
4. I failed to buy C at $1 when Big-timers knew they were finished.
5. I failed to buy DNDN at $3 when many of us thought it a scam.

Want more theorem's? What theorem do you derive from today's MNTA market cap? I only deal with Axioms:
MNTA has the ONLY FDA approval for AB-rated generic Lovenox and Sandoz is stuffing the channel.
Fire away...

BTW, irt some posters "worries" about supply constraints and ramping of production, I believe those worries to be innocently misguided. Sandoz has had years to mull this issue and I'm quite confident it will not be a limiting factor going forward. Besides, they had substantial stock on hand for immediate launch and taking of significant market share from Day 1.